HYBCAP
Dead / Abandoned — Abandoned — failure to respond (as of 21 Jul 2022)
What this means for you
This application is over — abandoned 08 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79317596
- Mark type
- Stylized text
- Filed
- 16 Apr 2021
- Abandoned
- 08 Jul 2022
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research; assays and reagents used for molecular biology research; assays and reagents used for clinical research; assays and reagents used for basic research; assays and reagents used for medical research; chemical reagents for non-medical purposes; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; reagents for research purposes; reagents for scientific or medical research use; reagents used for next generation sequencing; chemicals used for next generation sequencing; nucleic acids used for next generation sequencing; nucleic acids and chemical reagents for other than medical and veterinary purposes; nucleic acid sequences used for next generation sequencing
- Class 005 — Pharmaceuticals: Pharmaceutical, veterinary and medical preparations; diagnostic preparations and substances for medical purposes; clinical diagnostic reagents; clinical diagnostic chemicals; molecular diagnostic reagents; molecular diagnostic chemicals; clinical reagent kits for genetic medical diagnosis; nucleic acid sequences for use in clinical genotyping; nucleic acid sequences for use in clinical testing; nucleic acid sequences used for medical testing; nucleic acid sequences used for diagnostic testing; test kits for diagnostic applications in the medical and veterinary field; assays and reagents for use in medical or veterinary purposes; assays and reagents used in molecular diagnostics; assays and reagents used in clinical diagnostics; substances for use in medical assays; biochemical reagents commonly known as probes, for detecting and analyzing molecules in medical or clinical samples; chemical reagents for medical purposes; nucleic acid sequences and chemical reagents for medical and veterinary purposes; reagents for medical and veterinary purposes; reagents for medical use; reagents used for clinical, medical or diagnostic next generation sequencing; chemicals used for clinical, medical or diagnostic next generation sequencing; nucleic acids used for clinical, medical or diagnostic next generation sequencing; nucleic acids used for diagnostic testing; nucleic acids used for medical and veterinary purposes
Owner
- Lucigen Corporation, WI, US
Prosecution history
- 14 Aug 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 21 Jul 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Jul 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Apr 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Feb 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 29 Jan 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Jan 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 18 Jan 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 21 Jul 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 21 Jul 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 30 Jan 2022 — REFUSAL PROCESSED BY IB
- 07 Jan 2022 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 07 Jan 2022 — REFUSAL PROCESSED BY MPU
- 16 Dec 2021 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 15 Dec 2021 — NON-FINAL ACTION WRITTEN